由于美国OTC需求疲软,供应问题和通货膨胀,Prestige消费者医疗降低了前景. Prestige Consumer Healthcare lowered its outlook due to weak U.S. OTC demand, supply issues, and inflation.

Prestige Consumer Healthcare 公布的最新季度收入和收益低于预期，原因是美国对非处方产品的需求疲软、供应链问题和竞争加剧。 Prestige Consumer Healthcare reported lower-than-expected revenue and earnings for its latest quarter, citing weak demand for over-the-counter products in the U.S., supply chain issues, and increased competition. 该公司削减了全年展望,将衰退归咎于通货膨胀、消费支出的变动以及大规模需求后的变化。 The company cut its full-year outlook, attributing the slump to inflation, shifting consumer spending, and post-pandemic demand changes. 尽管面临种种挑战,但波黑银行强调指出,其资产负债表强劲,数字营销和电子商务投资不断进行,而投资者对其重新获得势头的能力仍持谨慎态度。 Despite the challenges, PBH highlighted a strong balance sheet and ongoing investments in digital marketing and e-commerce, while investors remain cautious about its ability to regain momentum.